Judge Orders FDA To Turn Over Documents In Spying Case
July 27, 2012
On July 23, 2012, a federal judge ordered the U.S. Food and Drug Administration to turn over previously undisclosed documents to attorneys for former and current employees of the FDA who claim that the FDA illegally spied on them after they reported allegedly improper medical device approvals by t[...]
Continue Reading
Are Secret Deals Among Drug Companies Costing You Money?
October 27, 2011
The U.S. Federal Trade Commission (“FTC”) has reported that name-brand drug manufacturers will cost U.S. taxpayers billions of dollars over a 10 year period by paying generic drug manufacturers to delay their introduction of lower-cost generic alternatives to brand-name drugs. The[...]
Continue Reading
